ARCHIVES

FDA Proposal On Dissemination of Off-Label Drug Information Doesn’t Go Far Enough, Cancer Groups Say

This article is from The Cancer Letter archive.

Vol. 22 No. 04 | January 26, 1996

Download PDF Visit The Full Archive

Related Articles

Nevins Retracts Key Paper By Duke Group, Raising Question Of Harm To Patients

October 29, 2010

Reports of SPOREs cut Premature, Broder Says, Wait for Peer Review

March 13, 1992

Greatest Need Of Cancer Care Givers: “Will to Work Together,” ACCC President Anderson Says

August 15, 1986

Fisher, NSABP Executive Committee, File Injunction Seeking Herberman’s Removal

August 12, 1994

NCI-Approved Clinical Trials

June 24, 2005

Change In Method Of Counting Cancer Incidence Results In More Attributed To Work Hazards

October 6, 1978